お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は多発性硬化症の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは多発性硬化症の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の多発性硬化症の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは多発性硬化症の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に多発性硬化症の治療市場を分類しています。本研究に含まれる主な企業は：Pfizer、Merck & Co、Teva Pharmaceutical、Sanofi、Bayer、Biogen、Roche、Novartis、CinnaGen、Mylan、Bristol-Myers Squibb、Janssen Pharmaceuticals、Acorda Therapeutics

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Immunomodulatory
    Immunosuppressive
    Interferons
    Others

用途別の市場セグメント：
    Hospital Pharmacy
    Retail Pharmacy
    Online Stores

本レポートの詳細内容
世界の多発性硬化症の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、多発性硬化症の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の多発性硬化症の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の多発性硬化症の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、多発性硬化症の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

多発性硬化症の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：多発性硬化症の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：多発性硬化症の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章多発性硬化症の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：多発性硬化症の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：多発性硬化症の治療の主要企業の概要を提供し、製品の説明と仕様、多発性硬化症の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.
Market Analysis and Insights: Global Multiple Sclerosis Treatment Market
The global Multiple Sclerosis Treatment market is projected to grow from US$ 17750 million in 2024 to US$ 19990 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Multiple Sclerosis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Multiple Sclerosis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Multiple Sclerosis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Multiple Sclerosis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Multiple Sclerosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Sales Channel, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Multiple Sclerosis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Merck & Co, Teva Pharmaceutical, Sanofi, Bayer, Biogen, Roche, Novartis and CinnaGen, etc.

Market Segmentation
By Company
    Pfizer
    Merck & Co
    Teva Pharmaceutical
    Sanofi
    Bayer
    Biogen
    Roche
    Novartis
    CinnaGen
    Mylan
    Bristol-Myers Squibb
    Janssen Pharmaceuticals
    Acorda Therapeutics

Segment by Type
    Immunomodulatory
    Immunosuppressive
    Interferons
    Others

Segment by Sales Channel
    Hospital Pharmacy
    Retail Pharmacy
    Online Stores

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Multiple Sclerosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiple Sclerosis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Sales Channel and by country, revenue for each segment.
Chapter 7: Europe by Type, by Sales Channel and by country, revenue for each segment.
Chapter 8: China by Type, and by Sales Channel, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Sales Channel and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Sales Channel and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multiple Sclerosis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Immunomodulatory
    Table 3. Key Players of Immunosuppressive
    Table 4. Key Players of Interferons
    Table 5. Key Players of Others
    Table 6. Global Multiple Sclerosis Treatment Market Size Growth Rate by Sales Channel (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Multiple Sclerosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Multiple Sclerosis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Multiple Sclerosis Treatment Market Share by Region (2019-2024)
    Table 10. Global Multiple Sclerosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Multiple Sclerosis Treatment Market Share by Region (2025-2030)
    Table 12. Multiple Sclerosis Treatment Market Trends
    Table 13. Multiple Sclerosis Treatment Market Drivers
    Table 14. Multiple Sclerosis Treatment Market Challenges
    Table 15. Multiple Sclerosis Treatment Market Restraints
    Table 16. Global Multiple Sclerosis Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Multiple Sclerosis Treatment Revenue Share by Players (2019-2024)
    Table 18. Global Top Multiple Sclerosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Treatment as of 2023)
    Table 19. Global Multiple Sclerosis Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Multiple Sclerosis Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Multiple Sclerosis Treatment, Headquarters and Area Served
    Table 22. Global Key Players of Multiple Sclerosis Treatment, Product and Application
    Table 23. Global Key Players of Multiple Sclerosis Treatment, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Multiple Sclerosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2019-2024)
    Table 27. Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2025-2030)
    Table 29. Global Multiple Sclerosis Treatment Market Size by Sales Channel (2019-2024) & (US$ Million)
    Table 30. Global Multiple Sclerosis Treatment Revenue Share by Sales Channel (2019-2024)
    Table 31. Global Multiple Sclerosis Treatment Forecasted Market Size by Sales Channel (2025-2030) & (US$ Million)
    Table 32. Global Multiple Sclerosis Treatment Revenue Share by Sales Channel (2025-2030)
    Table 33. North America Multiple Sclerosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Multiple Sclerosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Multiple Sclerosis Treatment Market Size by Sales Channel (2019-2024) & (US$ Million)
    Table 36. North America Multiple Sclerosis Treatment Market Size by Sales Channel (2025-2030) & (US$ Million)
    Table 37. North America Multiple Sclerosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Multiple Sclerosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Multiple Sclerosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Multiple Sclerosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Multiple Sclerosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Multiple Sclerosis Treatment Market Size by Sales Channel (2019-2024) & (US$ Million)
    Table 43. Europe Multiple Sclerosis Treatment Market Size by Sales Channel (2025-2030) & (US$ Million)
    Table 44. Europe Multiple Sclerosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Multiple Sclerosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Multiple Sclerosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Multiple Sclerosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Multiple Sclerosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Multiple Sclerosis Treatment Market Size by Sales Channel (2019-2024) & (US$ Million)
    Table 50. China Multiple Sclerosis Treatment Market Size by Sales Channel (2025-2030) & (US$ Million)
    Table 51. Asia Multiple Sclerosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Multiple Sclerosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Multiple Sclerosis Treatment Market Size by Sales Channel (2019-2024) & (US$ Million)
    Table 54. Asia Multiple Sclerosis Treatment Market Size by Sales Channel (2025-2030) & (US$ Million)
    Table 55. Asia Multiple Sclerosis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Multiple Sclerosis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Multiple Sclerosis Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Sales Channel (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Sales Channel (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Pfizer Company Details
    Table 66. Pfizer Business Overview
    Table 67. Pfizer Multiple Sclerosis Treatment Product
    Table 68. Pfizer Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 69. Pfizer Recent Developments
    Table 70. Merck & Co Company Details
    Table 71. Merck & Co Business Overview
    Table 72. Merck & Co Multiple Sclerosis Treatment Product
    Table 73. Merck & Co Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 74. Merck & Co Recent Developments
    Table 75. Teva Pharmaceutical Company Details
    Table 76. Teva Pharmaceutical Business Overview
    Table 77. Teva Pharmaceutical Multiple Sclerosis Treatment Product
    Table 78. Teva Pharmaceutical Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 79. Teva Pharmaceutical Recent Developments
    Table 80. Sanofi Company Details
    Table 81. Sanofi Business Overview
    Table 82. Sanofi Multiple Sclerosis Treatment Product
    Table 83. Sanofi Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 84. Sanofi Recent Developments
    Table 85. Bayer Company Details
    Table 86. Bayer Business Overview
    Table 87. Bayer Multiple Sclerosis Treatment Product
    Table 88. Bayer Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 89. Bayer Recent Developments
    Table 90. Biogen Company Details
    Table 91. Biogen Business Overview
    Table 92. Biogen Multiple Sclerosis Treatment Product
    Table 93. Biogen Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 94. Biogen Recent Developments
    Table 95. Roche Company Details
    Table 96. Roche Business Overview
    Table 97. Roche Multiple Sclerosis Treatment Product
    Table 98. Roche Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 99. Roche Recent Developments
    Table 100. Novartis Company Details
    Table 101. Novartis Business Overview
    Table 102. Novartis Multiple Sclerosis Treatment Product
    Table 103. Novartis Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 104. Novartis Recent Developments
    Table 105. CinnaGen Company Details
    Table 106. CinnaGen Business Overview
    Table 107. CinnaGen Multiple Sclerosis Treatment Product
    Table 108. CinnaGen Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 109. CinnaGen Recent Developments
    Table 110. Mylan Company Details
    Table 111. Mylan Business Overview
    Table 112. Mylan Multiple Sclerosis Treatment Product
    Table 113. Mylan Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 114. Mylan Recent Developments
    Table 115. Bristol-Myers Squibb Company Details
    Table 116. Bristol-Myers Squibb Business Overview
    Table 117. Bristol-Myers Squibb Multiple Sclerosis Treatment Product
    Table 118. Bristol-Myers Squibb Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 119. Bristol-Myers Squibb Recent Developments
    Table 120. Janssen Pharmaceuticals Company Details
    Table 121. Janssen Pharmaceuticals Business Overview
    Table 122. Janssen Pharmaceuticals Multiple Sclerosis Treatment Product
    Table 123. Janssen Pharmaceuticals Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 124. Janssen Pharmaceuticals Recent Developments
    Table 125. Acorda Therapeutics Company Details
    Table 126. Acorda Therapeutics Business Overview
    Table 127. Acorda Therapeutics Multiple Sclerosis Treatment Product
    Table 128. Acorda Therapeutics Revenue in Multiple Sclerosis Treatment Business (2019-2024) & (US$ Million)
    Table 129. Acorda Therapeutics Recent Developments
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Multiple Sclerosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Multiple Sclerosis Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Immunomodulatory Features
    Figure 4. Immunosuppressive Features
    Figure 5. Interferons Features
    Figure 6. Others Features
    Figure 7. Global Multiple Sclerosis Treatment Market Size Growth Rate by Sales Channel, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2023 VS 2030
    Figure 9. Hospital Pharmacy Case Studies
    Figure 10. Retail Pharmacy Case Studies
    Figure 11. Online Stores Case Studies
    Figure 12. Multiple Sclerosis Treatment Report Years Considered
    Figure 13. Global Multiple Sclerosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Multiple Sclerosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Multiple Sclerosis Treatment Market Share by Region: 2023 VS 2030
    Figure 16. Global Multiple Sclerosis Treatment Market Share by Players in 2023
    Figure 17. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Treatment as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Multiple Sclerosis Treatment Revenue in 2023
    Figure 19. North America Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Multiple Sclerosis Treatment Market Share by Type (2019-2030)
    Figure 21. North America Multiple Sclerosis Treatment Market Share by Sales Channel (2019-2030)
    Figure 22. North America Multiple Sclerosis Treatment Market Share by Country (2019-2030)
    Figure 23. United States Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Multiple Sclerosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Multiple Sclerosis Treatment Market Share by Type (2019-2030)
    Figure 27. Europe Multiple Sclerosis Treatment Market Share by Sales Channel (2019-2030)
    Figure 28. Europe Multiple Sclerosis Treatment Market Share by Country (2019-2030)
    Figure 29. Germany Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Multiple Sclerosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Multiple Sclerosis Treatment Market Share by Type (2019-2030)
    Figure 37. China Multiple Sclerosis Treatment Market Share by Sales Channel (2019-2030)
    Figure 38. Asia Multiple Sclerosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Multiple Sclerosis Treatment Market Share by Type (2019-2030)
    Figure 40. Asia Multiple Sclerosis Treatment Market Share by Sales Channel (2019-2030)
    Figure 41. Asia Multiple Sclerosis Treatment Market Share by Region (2019-2030)
    Figure 42. Japan Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Sales Channel (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Country (2019-2030)
    Figure 52. Brazil Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Multiple Sclerosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 59. Merck & Co Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 60. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 61. Sanofi Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 62. Bayer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 63. Biogen Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 64. Roche Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 65. Novartis Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 66. CinnaGen Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 67. Mylan Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 69. Janssen Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 70. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Treatment Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed